Sonoma Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
If you are employed by Sonoma Pharmaceuticals Inc and you wish to use your ESG rating, please contact us. This Disclosure score includes seventeen United Nations Sustainable Development Goals including: 'Gender Equality', 'Reduced Inequalities' and 'Life below Water'. This article contains a questions and answers table on Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Sonoma Pharmaceuticals Inc | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sonoma Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sonoma Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sonoma Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sonoma Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Sonoma Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sonoma Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sonoma Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.